COVID 19 Update in Children (2022)
This module was recorded at the Conversations and Conundrums - Current Clinical Pediatrics Virtual Meetingon Friday April 29, 2022. All material was current as of the day of presentation. This course is available until June 16, 2022.
This one hour recording provides an update on COVID 19 in Children including the following:
- Current COVID cases and seroprevalence rates in children
- Long term COVID and areas of emerging evidence and uncertainty
- Goals of COVID vaccination for children
- Pfizer/BioNTech COVID vaccine study in children 5-11
- Moderna study of COVID vaccine in children 6 mo- 5 yrs
- COVID vaccine safety
The content may be accessed at no charge but to receive the slides and a CME or CNE certificate, there is a $20 administrative fee.
Target Audience
This program is designed and certified for the entire pediatric healthcare team: primary care physicians, pediatricians, pediatric nurse practitioners, nurses, physician assistants, social workers, child mental health professionals and family nurse practitioners.
Learning Objectives
At the end of this program, attendees should be able to:
- Summarize the latest information on COVID cases and vaccinations in children.
- List one risk factor for severe illness for COVID in children.
- Describe a current COVID 19 treatment guideline
This module was recorded at the Virtual Meeting on Friday April 29, 2022. All material was current as of the day of presentation.
This one hour recording provide as update on COVID 19 in Childrent including the following:
- Current COVID cases and seroprevalence rates in children
- Long term COVID and areas of emerging evidence and uncertainty
- Goals of COVID vaccination for children
- Pfizer/BioNTech COVID vaccine study in children 5-11
- Moderna study of COVID vaccine in children 6 mo- 5 yrs
- COVID vaccine safety
Faculty/Planning Committee
Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors, and anyone who may be in control of content have been mitigated.
Jodi Wenger, MD
Course Director
Assistant Professor of Pediatrics
Boston University School of Medicine
Comprehensive Care Program, Grow Clinic
Boston Medical Center
Speaker owns stock in Doximity, Beclen, Dickinson & Co and Thermo Fischer Scientific. Speaker does plan on discussing unlabeled/investigational uses of a commercial product
Rachel Amgott MSN, RN, CPNP-PC
CNE Course Advisor
Pediatric Nurse Practitioner | Boston Medical Center
Department of Pediatrics | Division of Developmental and Behavioral Pediatrics
Assistant Professor of Pediatrics| Boston University School of Medicine
Planner has no relevant financial relationships to disclose.
Vishakha Sabharwal MD
Assistant Professor of Pediatrics
Attending Pediatrics Infectious Diseases
Associate Program Director, Pediatrics Infectious Diseases
Boston Medical Center
Speaker has no relevant financial relationships to disclose. Speaker does plan on discussing unlabeled/investigational uses of a commercial product
Jack Maypole, MD
CME Course Co-Director
Clinical Associate Professor in Pediatrics, BUSM/BMC
Vice Chair of Population Health and Practice Transformation
Director, Comprehensive Care Program (CCP) Medical Director, Special Kids Special Care Program Medical
Planner has no relevant financial relationships to disclose.
Carmela A. Townsend, DNP, MS/MBA, RN
Accredited Provider Activity Director
Continuing Medical Education Office, Boston University School of Medicine
Planner has no relevant financial relationships to disclose.
CME Program Manager: Claire P. Grimble, CMP
Program manager has no relevant financial relationships to disclose.
Physician Accreditation
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Accreditation
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation
Contact Hours: 1.00 of which 1 is eligible for pharmacology credit.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC
- 1.00 Participation
Price
You may watch the video at no charge. In order to earn credit, after watching the video, complete the $20 payment and,complete the evaluation. You may then claim your credit. Your certificate will be available immediately for download.
Faculty disclosure information can be found on the faculty tab above.
Disclaimer
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTHCARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
©BUSM 2022. All Rights Reserved.